236 related articles for article (PubMed ID: 8443815)
21. Use of immunotoxin to inhibit proliferating human corneal endothelium.
Fulcher S; Lui GM; Houston LL; Ramakrishnan S; Burris T; Polansky J; Alvarado J
Invest Ophthalmol Vis Sci; 1988 May; 29(5):755-9. PubMed ID: 3259213
[TBL] [Abstract][Full Text] [Related]
22. In vitro and in vivo antitumor activity of ZENECA ZD0490, a recombinant ricin A-chain immunotoxin for the treatment of colorectal cancer.
Calvete JA; Newell DR; Wright AF; Rose MS
Cancer Res; 1994 Sep; 54(17):4684-90. PubMed ID: 8062265
[TBL] [Abstract][Full Text] [Related]
23. Intraventricular immunotoxin therapy for leptomeningeal neoplasia.
Laske DW; Muraszko KM; Oldfield EH; DeVroom HL; Sung C; Dedrick RL; Simon TR; Colandrea J; Copeland C; Katz D; Greenfield L; Groves ES; Houston LL; Youle RJ
Neurosurgery; 1997 Nov; 41(5):1039-49; discussion 1049-51. PubMed ID: 9361057
[TBL] [Abstract][Full Text] [Related]
24. Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2.
Xu F; Leadon SA; Yu Y; Boyer CM; O'Briant K; Ward K; McWatters A; Zhao X; Bae DS; DeSombre K; Zalutsky MR; Bast RC
Clin Cancer Res; 2000 Aug; 6(8):3334-41. PubMed ID: 10955821
[TBL] [Abstract][Full Text] [Related]
25. Influence of cellular trafficking on protein synthesis inhibition of immunotoxins directed against the transferrin receptor.
Yazdi PT; Wenning LA; Murphy RM
Cancer Res; 1995 Sep; 55(17):3763-71. PubMed ID: 7641191
[TBL] [Abstract][Full Text] [Related]
26. In vitro and in vivo variation in transferrin receptor expression on a human medulloblastoma cell line.
Wen DY; Hall WA; Conrad J; Godal A; Flørenes VA; Fodstad O
Neurosurgery; 1995 Jun; 36(6):1158-63; discussion 1163-4. PubMed ID: 7643997
[TBL] [Abstract][Full Text] [Related]
27. Cytoreductive effects of anti-transferrin receptor immunotoxin in a multicellular tumor spheroid model.
Chignola R; Foroni R; Candiani C; Franceschi A; Pasti M; Stevanoni G; Anselmi C; Tridente G; Colombatti M
Int J Cancer; 1994 Apr; 57(2):268-74. PubMed ID: 8157364
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of human subconjunctival fibroblast proliferation by immunotoxin.
Wilkerson M; Fulcher S; Shields MB; Foulks GN; Hatchell DL; Houston LL
Invest Ophthalmol Vis Sci; 1992 Jun; 33(7):2293-8. PubMed ID: 1607241
[TBL] [Abstract][Full Text] [Related]
29. In situ expression of interleukin-4 (IL-4) receptors in human brain tumors and cytotoxicity of a recombinant IL-4 cytotoxin in primary glioblastoma cell cultures.
Joshi BH; Leland P; Asher A; Prayson RA; Varricchio F; Puri RK
Cancer Res; 2001 Nov; 61(22):8058-61. PubMed ID: 11719427
[TBL] [Abstract][Full Text] [Related]
30. Immunotherapeutic strategies in neuroblastoma: antitumoral activity of deglycosylated Ricin A conjugated anti-GD2 antibodies and anti-CD3xanti-GD2 bispecific antibodies.
Manzke O; Russello O; Leenen C; Diehl V; Bohlen H; Berthold F
Med Pediatr Oncol; 2001 Jan; 36(1):185-9. PubMed ID: 11464879
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of proliferating lens epithelium with antitransferrin receptor immunotoxin.
Goins KM; Ortiz JR; Fulcher SF; Handa JT; Jaffe GJ; Foulks GN; Cobo LM
J Cataract Refract Surg; 1994 Sep; 20(5):513-6. PubMed ID: 7996406
[TBL] [Abstract][Full Text] [Related]
32. Human melanoma cell lines showing striking inherent differences in sensitivity to immunotoxins containing holotoxins.
Godal A; Fodstad O; Morgan AC; Pihl A
J Natl Cancer Inst; 1986 Dec; 77(6):1247-53. PubMed ID: 3491924
[TBL] [Abstract][Full Text] [Related]
33. An immunotoxin cytotoxic for breast cancer cells in vitro.
LeMaistre CF; Edwards DP; Krolick KA; McGuire WL
Cancer Res; 1987 Feb; 47(3):730-4. PubMed ID: 3492266
[TBL] [Abstract][Full Text] [Related]
34. The antiproliferative effect of a transferrin-toxin on human retinal pigment epithelial cells and rabbit fibroblasts.
Handa JT; Houston LL; Jaffe GJ
Invest Ophthalmol Vis Sci; 1993 Nov; 34(12):3419-28. PubMed ID: 8225877
[TBL] [Abstract][Full Text] [Related]
35. Enhancement of the specific cytotoxicity of a breast cancer-associated antigen immunotoxin by the carboxylic ionophore monensin.
Griffin TW; Pagnini PG; Houston LL
J Biol Response Mod; 1987 Oct; 6(5):537-45. PubMed ID: 3500277
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of growth of human breast carcinoma cells by an antisense oligonucleotide targeted to the transferrin receptor gene.
Yang DC; Jiang XP; Elliott RL; Head JF
Anticancer Res; 2001; 21(3B):1777-87. PubMed ID: 11497259
[TBL] [Abstract][Full Text] [Related]
37. Enhanced therapeutic efficacy against an ovarian tumor xenograft of immunotoxins used in conjunction with recombinant alpha-interferon.
Pearson JW; Hedrick E; Fogler WE; Bull RL; Ferris DK; Riggs CW; Wiltrout RH; Sivam G; Morgan AC; Groves E
Cancer Res; 1990 Oct; 50(19):6379-88. PubMed ID: 2144790
[TBL] [Abstract][Full Text] [Related]
38. Changes in expression of transferrin, insulin-like growth factor 1, and interleukin 4 receptors after irradiation of cells of primary malignant brain tumor cell lines.
Kim KU; Xiao J; Ni HT; Cho KH; Spellman SR; Low WC; Hall WA
Radiat Res; 2003 Aug; 160(2):224-31. PubMed ID: 12859234
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of human corneal epithelium with immunotoxin 454A12-rRA.
Fulcher SF; Foulks GN; Wilkerson M; Cobo LM; Jaffe GJ; Hatchell DL
Cornea; 1992 Sep; 11(5):413-7. PubMed ID: 1424670
[TBL] [Abstract][Full Text] [Related]
40. Combined effects of radiation and interleukin-13 receptor-targeted cytotoxin on glioblastoma cell lines.
Kawakami K; Kawakami M; Liu Q; Puri RK
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):230-7. PubMed ID: 16111594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
